Literature DB >> 24694554

A prospective comparison of 3 approved systems for autologous bone marrow concentration demonstrated nonequivalency in progenitor cell number and concentration.

Vishal Hegde1, Owolabi Shonuga, Scott Ellis, Austin Fragomen, John Kennedy, Valery Kudryashov, Joseph M Lane.   

Abstract

OBJECTIVES: To evaluate the efficacy of 3 commercially available systems: the Harvest SmartPReP 2 BMAC, Biomet BioCUE, and Arteriocyte Magellan systems. We compared the number and concentration of progenitor cells achieved both before and after centrifugation and the percentage of progenitor cells salvaged after centrifugation.
METHODS: Forty patients, mean age 47 ± 18 years (range: 18-92 years, 19 male/21 female) were prospectively consented for bilateral iliac crest aspiration. The first 20 aspirations compared the Harvest and Biomet systems, and based on those results, the second 20 compared the Harvest and Arteriocyte systems. One system was randomly assigned to each iliac crest. Each system's unique marrow acquisition process and centrifugation mechanism was followed. Samples for analysis were taken both immediately before the marrow was put into the centrifugation system (after acquisition), and after centrifugation. The number of progenitor cells in each sample was estimated by counting the connective tissue progenitors (CTPs).
RESULTS: The Harvest system achieved a significantly greater number and concentration of CTPs both before and after centrifugation when compared to the Biomet system. There was no difference in the percent yield of CTPs after centrifugation. There was no significant difference in the number and concentration of CTPs between the Harvest and Arteriocyte systems before centrifugation, but the Harvest system had a significantly greater number and concentration of CTPs after centrifugation. The Harvest system also had a significantly higher percent yield of CTPs after centrifugation compared with the Arteriocyte system.
CONCLUSIONS: The Harvest system resulted in a greater CTP number and concentration after centrifugation when compared with the Biomet and Arteriocyte systems and may thus provide increased osteogenic and chondrogenic capacity.

Entities:  

Mesh:

Year:  2014        PMID: 24694554     DOI: 10.1097/BOT.0000000000000113

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  18 in total

1.  Combination of Filtered Bone Marrow Aspirate and Biomimetic Scaffold for the Treatment of Knee Osteochondral Lesions: Cellular and Early Clinical Results of a Single Centre Case Series.

Authors:  Matija Veber; Jan Vogler; Miomir Knežević; Ariana Barlič; Matej Drobnič
Journal:  Tissue Eng Regen Med       Date:  2020-04-23       Impact factor: 4.169

Review 2.  The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis.

Authors:  Stuart B Goodman
Journal:  Int Orthop       Date:  2018-02-12       Impact factor: 3.075

Review 3.  A Review of Commercially Available Point-of-Care Devices to Concentrate Bone Marrow for the Treatment of Osteoarthritis and Focal Cartilage Lesions.

Authors:  Florian Gaul; William D Bugbee; Heinz R Hoenecke; Darryl D D'Lima
Journal:  Cartilage       Date:  2018-04-13       Impact factor: 4.634

Review 4.  Management of Posttraumatic Ankle Arthritis: Literature Review.

Authors:  Samuel O Ewalefo; Malcolm Dombrowski; Takashi Hirase; Jorge L Rocha; Mitchell Weaver; Alex Kline; Dwayne Carney; MaCalus V Hogan
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 5.  Modifying MSC Phenotype to Facilitate Bone Healing: Biological Approaches.

Authors:  Stuart B Goodman; Tzuhua Lin
Journal:  Front Bioeng Biotechnol       Date:  2020-06-24

6.  Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration.

Authors:  Jennifer M Cassano; John G Kennedy; Keir A Ross; Ethan J Fraser; Margaret B Goodale; Lisa A Fortier
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-01       Impact factor: 4.342

7.  A single step, centrifuge-free method to harvest bone marrow highly concentrated in mesenchymal stem cells: results of a pilot trial.

Authors:  Marco Viganò; Enrico Ragni; Berardo Di Matteo; Francesco Manlio Gambaro; Carlotta Perucca Orfei; Giuseppina Spinelli; Alessandra Colombini; Laura de Girolamo; Elizaveta Kon
Journal:  Int Orthop       Date:  2021-11-02       Impact factor: 3.479

8.  Quantitative Assessment of Optimal Bone Marrow Site for the Isolation of Porcine Mesenchymal Stem Cells.

Authors:  J S McDaniel; B Antebi; M Pilia; B J Hurtgen; S Belenkiy; C Necsoiu; L C Cancio; C R Rathbone; A I Batchinsky
Journal:  Stem Cells Int       Date:  2017-04-30       Impact factor: 5.443

9.  Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration.

Authors:  Richard Schäfer; Malcolm R DeBaun; Erika Fleck; Christopher J Centeno; Daniela Kraft; Johannes Leibacher; Karen Bieback; Erhard Seifried; Jason L Dragoo
Journal:  J Transl Med       Date:  2019-04-08       Impact factor: 5.531

10.  Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation.

Authors:  Michael Scarpone; Daniel Kuebler; Andrew Chambers; Carlo Maria De Filippo; Mariangela Amatuzio; Thomas E Ichim; Amit N Patel; Eugenio Caradonna
Journal:  J Transl Med       Date:  2019-01-05       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.